August 11, 2025
Luc Gagnon, IQVIA Laboratories’ global head of vaccine sciences, appointed to CEPI’s Global Central Laboratory Network Advisory Council
.
August 11, 2025
IQVIA Laboratories wins Vaccine Industry Excellence Award for Best Central/Specialty Laboratory for second consecutive year
.
March 4, 2025
IQVIA Laboratories Launches Site Lab Navigator with Breakthrough e-Requisition Innovation to Transform Clinical Trials
IQVIA Laboratories launches Site Lab Navigator, an advanced e-Requisition ...
October 9, 2024
IQVIA Laboratories Opens New State-of-the-Art Facility in Valencia, CA
IQVIA Laboratories announces the expansion and relocation of its Central ...
April 19, 2023
Q² Solutions strengthens scalable, next generation sequencing approaches with Illumina’s NovaSeq™ X Plus platform solution, enhancing data quality and analysis capabilities with sustainable operations
Expanding on deep expertise with industry-leading solutions to meet the unique ...
April 3, 2023
Q² Solutions Scotland-based Central Laboratory Achieves My Green Lab Program Certification
Showcasing commitment to sustainable laboratory practices, Q² Solutions is ...
March 31, 2023
Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
Specifica is a rapidly growing antibody engineering company specializing in the ...
January 24, 2023
Q² Solutions Presents Benefits of Innovative Tech-Enabled End-to-End Sample and Consent Management at 14th Annual SCOPE Summit
Vital for trial sponsors looking to enhance trial efficiencies with quality and ...
November 16, 2022
Q² Solutions’ next-generation single cell RNA sequencing methodology: increasing throughput with enhanced high quality assessments
Single cell RNA sequencing is playing an integral role in innovative ...
October 14, 2022
